cannabis indica

Índice completo — página 39 de 77

Estudos 3.801 a 3.900 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2019. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 3.801 a 3.900

  1. 2019

    Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting

    FavorávelMetanáliseNáusea e VômitoNáusea e Vômito por Quimioterapia
  2. 2019

    Cannabis Abuse or Dependence During Pregnancy: A Population-Based Cohort Study on 12 Million Births

    DesfavorávelMetanáliseGestação
  3. 2019

    Cannabis acute use impacts symptoms and functionality in a cohort of antipsychotic naïve First Episode of Psychosis individuals

    DesfavorávelMetanálisePsicoseEsquizofrenia
  4. 2019

    Cannabis allergy: what the clinician needs to know in 2019

    DesfavorávelMetanáliseAlergia à Cannabis
  5. 2019

    Cannabis and acute coronary syndrome with ST segment elevation

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)Arritmias Cardíacas
  6. 2019

    Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential

    DesfavorávelMetanáliseAnsiedadeDepressãoTEPT+1
  7. 2019

    Cannabis and Cannabinoids in Palliative Care

    FavorávelMetanáliseCuidados Paliativos
  8. 2019

    Cannabis and Cannabinoids on Treatment of Inflammation: A Patent Review

    FavorávelMetanáliseInflamação
  9. 2019

    Cannabis and Epilepsy

  10. 2019

    Cannabis and Hearing Care: Hearing Loss and Tinnitus

    InconclusivoMetanáliseZumbidoPerda Auditiva
  11. 2019

    Cannabis and Male Fertility: A Systematic Review

    DesfavorávelMetanáliseInfertilidade Masculina
  12. 2019

    Cannabis and Mood Disorders

    InconclusivoMetanáliseDepressãoTranstorno Bipolar
  13. 2019

    Cannabis and multiple sclerosis

    FavorávelMetanáliseEsclerose Múltipla
  14. 2019

    Cannabis and Psychosis Through the Lens of DSM-5

    InconclusivoMetanáliseEfeitos Adversos da CannabisPsicoseEsquizofrenia
  15. 2019

    Cannabis and Psychosis: Are We any Closer to Understanding the Relationship?

    InconclusivoMetanálisePsicoseEsquizofrenia
  16. 2019

    Cannabis and psychosis: revisiting a nineteenth century study of 'Indian Hemp and Insanity' in Colonial British India

    InconclusivoMetanálisePsicoseEsquizofrenia
  17. 2019

    Cannabis and psychosis: triangulating the evidence

    DesfavorávelMetanálisePsicose
  18. 2019

    Cannabis and symptoms of PMS and PMDD

    FavorávelMetanáliseDistúrbios Menstruais
  19. 2019

    Cannabis and Turmeric as Complementary Treatments for IBD and Other Digestive Diseases.

  20. 2019

    Cannabis as a cause of death: A review

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  21. 2019

    Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients

    FavorávelMetanáliseFibroseEsteatose HepáticaFibrose — Hepática (Cirrose)
  22. 2019

    Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education

    InconclusivoMetanáliseDorEfeitos Adversos da CannabisAnsiedade+2
  23. 2019

    Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes

    DesfavorávelMetanáliseRejeição de Transplante
  24. 2019

    Cannabis Expectancies for Sleep

    FavorávelMetanáliseInsônia e Distúrbios do Sono
  25. 2019

    Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology

    FavorávelMetanáliseDorAnsiedadeNáusea e Vômito+2
  26. 2019

    Cannabis for Gastroparesis: Hype or Hope?

    InconclusivoMetanáliseGastroparesia
  27. 2019

    Cannabis for Neuropathic Pain in Multiple Sclerosis—High Expectations, Poor Data

    FavorávelMetanáliseEsclerose Múltipla
  28. 2019

    Cannabis for refractory epilepsy in children: A review focusing on CDKL5 Deficiency Disorder

  29. 2019

    Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews

  30. 2019

    Cannabis for the treatment of ulcerative colitis

  31. 2019

    Cannabis hyperemesis syndrome

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  32. 2019

    Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  33. 2019

    Cannabis hyperemesis syndrome: still under recognised after all these years

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  34. 2019

    Cannabis hyperemesis syndrome: still under recognized after all these years

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  35. 2019

    Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies

    InconclusivoMetanáliseCâncerCâncer — PulmãoCâncer — Melanoma+1
  36. 2019

    Cannabis in the Treatment of Traumatic Brain Injury: A Primer for Clinicians

    FavorávelMetanáliseDepressãoPsicoseTraumatismo Cranioencefálico
  37. 2019

    Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  38. 2019

    Cannabis Inhalation and Voice Disorders: A Systematic Review

    DesfavorávelMetanáliseEfeitos Adversos da CannabisFibroseFibrose — Pulmonar
  39. 2019

    Cannabis intoxication after accidental ingestion in infants: urine and plasma concentrations of Δ-9-tetrahydrocannabinol (THC), THC-COOH and 11-OH-THC in 10 patients

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  40. 2019

    Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial

  41. 2019

    Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain

    FavorávelMetanáliseInflamaçãoArtriteArtrite — Osteoartrite+2
  42. 2019

    Cannabis sativa as a Potential Treatment for Systemic Sclerosis

    FavorávelMetanáliseEsclerose Sistêmica
  43. 2019

    Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury

    FavorávelEstudo LaboratorialInflamaçãoCicatrizaçãoDermatite de Contato Alérgica+2
  44. 2019

    Cannabis Use and Acute Coronary Syndrome

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)Infarto
  45. 2019

    Cannabis Use and Markers of Systemic Inflammation: The Coronary Artery Risk Development in Young Adults Study

    InconclusivoMetanáliseInflamação
  46. 2019

    Cannabis use and psychosis: a review of reviews

    DesfavorávelMetanálisePsicoseEsquizofrenia
  47. 2019

    Cannabis Use and the Risk of Psychosis and Affective Disorders

    DesfavorávelMetanálisePsicoseEsquizofreniaTranstorno Bipolar
  48. 2019

    Cannabis use and the risk of tuberculosis: a systematic review

    InconclusivoMetanáliseTuberculose
  49. 2019

    Cannabis Use as a Risk Factor for Takotsubo (Stress) Cardiomyopathy: Exploring the Evidence from Brain-Heart Link

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)
  50. 2019

    Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis users

    InconclusivoMetanáliseDependência — CannabisAnsiedadeDepressão
  51. 2019

    Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016

    InconclusivoMetanáliseDependência QuímicaDependência — Cannabis
  52. 2019

    Cannabis Use Disorder and Epilepsy: A Cross-National Analysis of 657 072 Hospitalized Patients

    InconclusivoMetanáliseDependência — CannabisEpilepsia
  53. 2019

    Cannabis use disorder and suicide attempts in bipolar disorder: A meta-analysis

  54. 2019

    Cannabis use disorders among adults in the United States during a time of increasing use of cannabis

    InconclusivoMetanáliseDependência — Cannabis
  55. 2019

    Cannabis use disorders and psychiatric comorbidities

    InconclusivoMetanáliseDependência — CannabisAnsiedadePsicose
  56. 2019

    Cannabis use disorders may protect against certain disorders of the digestive organs in people with schizophrenia but not in healthy controls

  57. 2019

    Cannabis use disorders may protect against certain disorders of the digestive organs in people with schizophrenia but not in healthy controls

    InconclusivoMetanáliseDependência — CannabisPsicoseEsquizofrenia+1
  58. 2019

    Cannabis use in myotonic dystrophy patients in Germany and USA: a pilot survey

    FavorávelMetanáliseDistrofia Muscular e Distúrbios Miotônicos
  59. 2019

    Cannabis Use in Pregnancy in British Columbia and Selected Birth Outcomes

    DesfavorávelMetanáliseGestação
  60. 2019

    Cannabis use in subjects at ultra high risk for psychosis

    DesfavorávelMetanálisePsicoseEsquizofrenia
  61. 2019

    Cannabis use is associated with potentially heritable widespread changes in autism candidate gene DLGAP2 DNA methylation in sperm

    DesfavorávelEstudo LaboratorialEfeitos Adversos da CannabisAutismo
  62. 2019

    Cannabis use is both independently associated with and mediates worse psychosocial health in patients with epilepsy

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDepressãoEpilepsia
  63. 2019

    Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain

    InconclusivoMetanáliseDorDor — Crônica
  64. 2019

    Cannabis users: Screen systematically, treat individually. A descriptive study of participants in a randomized trial in primary care

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  65. 2019

    Cannabis-Associated Asthma and Allergies

    DesfavorávelMetanáliseAlergia à Cannabis
  66. 2019

    Cannabis-based medicines for chronic pain management: current and future prospects

    FavorávelMetanáliseDorDor — Crônica
  67. 2019

    Cannabis-based medicines for chronic pain: indications, selection of drugs, effectiveness and safety : Experiences of pain physicians in Saarland

    InconclusivoMetanáliseDorDor — CrônicaTHC Farmacêutico
  68. 2019

    Cannabis-based product use in a multiple sclerosis cohort

    FavorávelMetanáliseEsclerose Múltipla
  69. 2019

    Cannabis-based products for pediatric epilepsy: A systematic review

  70. 2019

    Cannabis-based treatments as an alternative remedy for epilepsy

  71. 2019

    Cannabis-derived medicines for the treatment of chronic pain : Problems resulting from medical appraisals in the experience of the Medical Advisory Board of the Statutory Health Insurance Funds North

    FavorávelMetanáliseDorDor — Crônica
  72. 2019

    Cannabis-induced altered states of consciousness are associated with specific dynamic brain connectivity states

    InconclusivoEnsaio ClínicoDisfunção CognitivaPsicoseTranstornos de Comportamento
  73. 2019

    Cannabis, a Significant Risk Factor for Violent Behavior in the Early Phase Psychosis. Two Patterns of Interaction of Factors Increase the Risk of Violent Behavior: Cannabis Use Disorder and Impulsivity; Cannabis Use Disorder, Lack of Insight and Treatment Adherence

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDependência — CannabisPsicose
  74. 2019

    Cannabis: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome

  75. 2019

    Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea

    FavorávelEstudo em AnimaisPerda Auditiva
  76. 2019

    Cardiovascular effects of marijuana

  77. 2019

    Caring for people with multiple sclerosis who use cannabis for symptom control

    FavorávelMetanáliseEsclerose Múltipla
  78. 2019

    CB1 positive allosteric modulation attenuates Δ9-THC withdrawal and NSAID-induced gastric inflammation.

    FavorávelEstudo em AnimaisDependência — CannabisCanabinoide Sintético (não especificado)
  79. 2019

    Cellular Distribution of Canonical and Putative Cannabinoid Receptors in Canine Cervical Dorsal Root Ganglia

    InconclusivoMetanáliseAplicações Veterinárias
  80. 2019

    Cerebellar alterations in cannabis users: A systematic review

    DesfavorávelMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+3
  81. 2019

    Characterising heterogeneity in the use of different cannabis products: latent class analysis with 55 000 people who use cannabis and associations with severity of cannabis dependence

    DesfavorávelMetanáliseDependência — Cannabis
  82. 2019

    Characterization of Cancer-Induced Nociception in a Murine Model of Breast Carcinoma

    FavorávelEstudo em AnimaisDorCâncerCâncer — MamaCanabinoides Sintéticos WIN-x+3
  83. 2019

    Characterization of Cannabis sativa allergens

    DesfavorávelMetanáliseAlergia à Cannabis
  84. 2019

    Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure

    DesfavorávelMetanálisePsicoseEsquizofrenia
  85. 2019

    Chemotherapy‐induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol

  86. 2019

    Chronic Marijuana and Synthetic Cannabinoid-Induced Toxic Myocarditis and End-Stage Cardiomyopathy: Management With Mechanical Circulatory Support as a Bridge-to-Transplantation

  87. 2019

    Clinical and cost-effectiveness of contingency management for cannabis use in early psychosis: the CIRCLE randomised clinical trial

  88. 2019

    Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study

  89. 2019

    CNR1 and FAAH variation and affective states induced by marijuana smoking

    InconclusivoEnsaio ClínicoDependência — CannabisAnsiedadeTranstornos de Comportamento
  90. 2019

    Co-ultraPEALut: Role in Preclinical and Clinical Delirium Manifestations

  91. 2019

    Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions

  92. 2019

    Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome

  93. 2019

    Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways

    FavorávelEstudo em AnimaisEsclerose MúltiplaTHC:CBD Farmacêutico
  94. 2019

    Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases

    FavorávelMetanáliseEpidermólise BolhosaTHC:CBD Farmacêutico
  95. 2019

    Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis

    DesfavorávelEnsaio ClínicoDisfunção CognitivaEsclerose Múltipla
  96. 2019

    Comparative Study of Alpha- And Beta-Pinene Effect on PTZ-induced Convulsions in Mice

    InconclusivoEstudo em AnimaisEpilepsia
  97. 2019

    Comparison of Cortisol Stress Response in Patients with Panic Disorder, Cannabis-Induced Panic Disorder, and Healthy Controls

    InconclusivoEnsaio ClínicoAnsiedade
  98. 2019

    Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood

    DesfavorávelEstudo em AnimaisAnsiedadeTEPT
  99. 2019

    Concomitant Treatment of Malignant Brain Tumours With CBD - A Case Series and Review of the Literature

    FavorávelEnsaio ClínicoCâncerCâncer — Cérebro
  100. 2019

    Consequences of Perinatal Cannabis Exposure

    DesfavorávelEstudo em AnimaisGestaçãoCanabinoide Sintético (não especificado)